ClinConnect ClinConnect Logo
Search / Trial NCT06706375

Compared Reversed US-Guided Dorsal Penile Nerve Block (RUSDPNB) with DPNB in Circumcisions for Pediatric Patients

Launched by CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS · Nov 22, 2024

Trial Information

Current as of August 27, 2025

Not yet recruiting

Keywords

Circumcision Reversed Ultrasound Guided Dorsal Penile Nerve Block

ClinConnect Summary

This clinical trial is studying two different methods of pain relief for boys undergoing circumcision, a common surgical procedure. The focus is on comparing a technique that uses ultrasound to guide the injection of anesthetic, called the Reversed Ultrasound-Guided Dorsal Penile Nerve Block (RUSDPNB), with the traditional method that uses anatomical landmarks to find the right spot for the injection, known as DPNB. The goal is to see if the ultrasound method provides better pain relief and fewer complications after surgery.

Boys aged 0 to under 18 who are scheduled for circumcision may be eligible to participate. If you choose to join the study, you will receive information about it ahead of time, and consent can be signed up to the day of the surgery. On the day of the procedure, you will meet the anesthesia team who will explain everything again. Participants will be randomly assigned to either the ultrasound group or the control group, but only the medical team will know which method each participant receives. Throughout the process, researchers will monitor pain levels and any side effects, as well as how much pain medication is needed after the operation. Importantly, participating in the trial will not change how your child's surgery is performed.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • male
  • undergoing circumcision
  • informed consent
  • Exclusion Criteria:
  • other surgery than circumcision in the same time
  • contraindication to local anesthesia
  • allergy to bupivacaine
  • chronic opiates treatment

About Centre Hospitalier Universitaire Vaudois

The Centre Hospitalier Universitaire Vaudois (CHUV) is a leading academic medical center located in Lausanne, Switzerland, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHUV plays a pivotal role in translating scientific discoveries into transformative therapies, enhancing patient care across a diverse range of medical disciplines. With a multidisciplinary team of experts and state-of-the-art facilities, CHUV is dedicated to fostering collaboration and delivering high-quality evidence that informs clinical practice and policy.

Locations

Lausanne, Vaud, Switzerland

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported